Alberta Investment Management Corp purchased a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 18,200 shares of the insurance provider’s stock, valued at approximately $4,735,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its position in shares of Humana by 273.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock valued at $907,541,000 after purchasing an additional 2,553,509 shares during the last quarter. Norges Bank purchased a new stake in Humana during the second quarter worth about $397,079,000. Bank of New York Mellon Corp raised its position in Humana by 161.5% in the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock worth $446,911,000 after acquiring an additional 1,060,767 shares during the period. Dodge & Cox boosted its stake in Humana by 5.6% in the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after acquiring an additional 597,705 shares during the last quarter. Finally, 8 Knots Management LLC boosted its stake in Humana by 671.0% in the second quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock valued at $107,968,000 after acquiring an additional 384,345 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on HUM shares. Zacks Research cut shares of Humana from a “hold” rating to a “strong sell” rating in a report on Thursday, January 1st. Truist Financial dropped their price target on Humana from $285.00 to $200.00 and set a “hold” rating on the stock in a research report on Tuesday. Morgan Stanley set a $146.00 price target on Humana in a research note on Thursday, February 12th. Evercore lowered their price objective on Humana from $260.00 to $180.00 in a research note on Thursday, February 12th. Finally, Robert W. Baird dropped their price objective on shares of Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a report on Thursday, December 11th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $228.48.
Humana Stock Performance
NYSE:HUM opened at $190.61 on Friday. Humana Inc. has a twelve month low of $169.61 and a twelve month high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock has a market cap of $22.92 billion, a P/E ratio of 19.41, a PEG ratio of 2.00 and a beta of 0.44. The business’s 50-day moving average price is $239.01 and its two-hundred day moving average price is $259.13.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. During the same period last year, the firm posted ($2.16) earnings per share. Humana’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.9%. Humana’s dividend payout ratio (DPR) is presently 36.05%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
